TABLE 1

Competition Binding Studies with PK11195, PBR28, PBR06, PBR111, DPA713, and DAA1106

Ki (nM) of…
Binding classPK11195*PBR28*PBR06DPA713DAA1106PBR111
HABs28.3 ± 4.0 (n = 6)3.4 ± 0.2 (n = 6)8.6 ± 2.0 (n = 5)15.0 ± 2.2 (n = 5)2.8 ± 0.3 (n = 4)15.6 ± 3.7 (n = 5)
LABs22.3 ± 2.2 (n = 5)188 ± 7.0 (n = 5)149 ± 46.6 (n = 4)66.4 ± 7.8 (n = 4)13.1 ± 1.3 (n = 4)61.8 ± 10.7 (n = 5)
MABs23.6 ± 5.5 (n = 4)Two receptors detected (n = 4): 4.0 ± 1.2 (high) and 313 ± 38 (low)Two receptors detected (n = 4): 13.4 ± 3.4 (high) and 176 ± 103 (low)26.8 ± 2.9 (n = 4)4.8 ± 0.4 (n = 4)30.3 ± 4.1 (n = 4)
Ki ratio of LAB to HAB0.855174.44.74.0
t test
 HAB vs. LABP < 0.25P < 0.0001P < 0.011P < 0.001P < 0.001P < 0.003
 MAB vs. LABP < 0.82NANAP < 0.003P < 0.001P < 0.04
 MAB vs. HABP < 0.50NANAP < 0.01P < 0.005P < 0.03
  • * Data reproduced from Owen et al. (6).

  • NA = not applicable.

  • Data are expressed as mean ± SEM. All data in Table 1 were generated from donors B1–B15, inclusive.